Just Healthcare

Just Healthcare

Analysis highlights limited benefits of antivirals for nonsevere influenza.

Insights from a Meta-Analysis on the Efficacy of Antivirals for Nonsevere Influenza Cases

Naveen Sankar S's avatar
Naveen Sankar S
Jan 28, 2025
∙ Paid
2
1
Share

Topline

A meta-analysis suggests that most antivirals, including oseltamivir and zanamivir, offer limited benefits for nonsevere influenza cases, while baloxavir shows potential for reducing symptom duration and hospitalization in high-risk patients.

Study Details

Influenza continues to pose significant health risks globally, particularly among high-risk p…

Keep reading with a 7-day free trial

Subscribe to Just Healthcare to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Just Healthcare
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture